IRVINE, California, October 8, 2010 /PRNewswire/ -- Interventional Spine(R), Inc. today announced the Company's unique PERPOS(R) Percutaneous Cervical System has been awarded the 2010 Best New Technology in Cervical Card Award at The Orthopedics This Week(R) Spine Technology Awards(R) Gala held in Orlando, FL, on October 4, 2010.
(Logo: http://photos.prnewswire.com/prnh/20100419/LA88318LOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20100419/LA88318LOGO)
The winners were selected by a panel of judges from leading orthopedic hospitals and institutions in the United States on a basis of their innovation and clinical relevance. The judges include experienced surgeons with clinical and research background, as well as venture capitalists with extensive experience in bringing new spine technologies to market.
Orthopedics This Week is the most widely read publication in the Orthopedics industry and they recognize exemplary and innovative spine surgery products and the engineering teams and inventors who create them.
The Chief Executive Officer of Interventional Spine(R), Inc., Walter A. Cuevas, commented, Receiving this recognition from the panel for our distinctive cervical technology is truly an honor, and one that recognizes the hard work of our engineers. It also cements Interventional Spine at the forefront of percutaneous technologies for the interventional treatment of back pain.
The PERPOS(R) Percutaneous Cervical System is the only product on the market that can stabilize the posterior cervical spine with a truly percutaneous procedure. Designed based on the experience gained with the use of its PERPOS(R) PLS lumbar system, in use in the United States since 2005, the company believes that its percutaneous approach to the cervical spine will minimize intra and post-operative patient morbidity, reduce procedure time and provide cost efficiencies to hospitals and surgeons alike.
The PERPOS(R) Percutaneous Cervical System includes a 3.8mm CS Facet Compression Device which is indicated for the treatment of Spondylolisthesis, Spondylolysis, Degenerative Disc Disease (DDD), degeneration of the facets with instability and fracture, Pseudoarthrosis, and also for patients that have failed previous fusion of the cervical spine. Its intended use is to stabilize the spine as an aid to fusion through bilateral immobilization of the facet joints via bilateral facet fixation, with or without bone graft, at single or multiple levels from C2 to S1.
Interventional Spine(R), Inc. is a privately held company based in Irvine, California, that designs, develops and markets patented implantable devices for the spine that can be deployed via percutaneous techniques. Supported by the Company's unique product introduction systems, Interventional Spine's products provide benefits to patients, surgeons and hospitals. More information on the Company and its products can be found at: http://www.i-spineinc.com.
FOR FURTHER INFORMATION CONTACT: Walter Cuevas Chief Executive Officer +1-949-472-0006
SOURCE: Interventional Spine, Inc.
CONTACT: Walter Cuevas, Chief Executive Officer of Interventional Spine,Inc., +1-949-472-0006
Comments